| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 09/14/2006 | US20060205666 Gamma-secretase inhibitors |
| 09/14/2006 | US20060205665 Non-basic amino acid sequence transporter peptide conjugated to biological effector; translocation across the membrane of eukaryotic cells |
| 09/14/2006 | US20060205638 Process for preparing macrocyclic compounds |
| 09/14/2006 | US20060205637 Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity |
| 09/14/2006 | US20060204966 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor |
| 09/14/2006 | CA2605122A1 Thyrotropin-releasing hormone analogs and method of use |
| 09/14/2006 | CA2600367A1 Process for preparing macrocyclic compounds |
| 09/14/2006 | CA2599723A1 Modified transferrin fusion proteins |
| 09/13/2006 | EP1700920A1 Synthetic antibiotics |
| 09/13/2006 | EP1699812A2 Inhibitors of methionine aminopeptidase-2 and uses thereof |
| 09/13/2006 | EP1699759A1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| 09/13/2006 | EP1699558A1 Removal of ruthenium by-product by supercritical fluid processing |
| 09/13/2006 | EP1442050B1 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 09/13/2006 | EP1302477B1 Peptide fructose and complex thereof with binding protein |
| 09/13/2006 | EP1221954B1 Methods for identifying inhibitors of methionine aminopeptidases |
| 09/13/2006 | EP1196431B1 A substantially crystalline form of melagatran |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1833031A Casein hydrolyzate, process for producing the same and use thereof |
| 09/13/2006 | CN1832958A Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 09/13/2006 | CN1831002A Synthesis of novel adenosine polypeptide compounds, and 99Tcm, 186Re tag and tag, and application in tumor treating medicines |
| 09/13/2006 | CN1831000A Synthesis of novel imurel substituted peptide compounds, and 99Tcm, 186 Re tagging, and tumor medicine, anoxic imaging agent |
| 09/13/2006 | CN1830989A Novel adenine polypeptide compounds synthesis and 99Tcm, 186Re tagging and the tag used in tumor and anoxic visulization |
| 09/13/2006 | CN1274714C Process for preparing aspartame |
| 09/13/2006 | CN1274713C Inhibitors of kallikrein |
| 09/13/2006 | CN1274712C Peptide derivative, and pharmaceutically acceptable salt thereof, process for producing the same, and use thereof |
| 09/12/2006 | US7105648 Oligomers substituted by phosphite acid ester, phosphonic acid or carbaborane functions and the corresponding PNA monomers |
| 09/12/2006 | US7105642 Monoclonal antibodies specific for phosphorylated estrogen receptor alpha (Ser118) and uses thereof |
| 09/12/2006 | US7105635 Cyclic beta-sheet peptides useful as apoptotic/cytotoxic cancer agents |
| 09/12/2006 | US7105539 such as N-[1-Carboxy-2-(1H-indol-3-yl)-ethyl]-3-(2-mercapto-acetylamino)-succinamic acid; endopeptidase (Phex/pex) inhibitors; for promoting generation of bone mass and treating or preventing diseases or conditions associated with phosphate metabolism defect; drug screening |
| 09/12/2006 | US7105488 inhibiting a target G protein-coupled receptor (GPCR) by contacting a cell that expresses GPCR with an isolated GPCR-modulating peptide; inhibits a biological activity of GPCR by disrupting the structure; antitumor, prevents binding of a virus and subsequent infection |
| 09/12/2006 | US7105483 Phosphinic pseudopeptide derivatives for the selective inhibition of the C-terminal active site of angiotensin I converting enzyme (ACE) |
| 09/12/2006 | US7105482 Administering {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester; parasitic infections, thymoma, and lymphoid malignancies; prevents the metabolic degradation of the angiogenesis inhibitor |
| 09/12/2006 | CA2277766C Sweetener composition improved in taste |
| 09/12/2006 | CA2241788C Novel n-(arylsulphonyl)amino acid derivatives, their preparation process and pharmaceutical compositions containing them |
| 09/12/2006 | CA2140929C Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 09/08/2006 | WO2006092722A1 Peptidomimetic compounds and preparation of biologically active derivatives |
| 09/08/2006 | WO2006092640A1 Antiproliferative peptides containing the motif phe-trp-leu, pharmaceutical compositions and medical uses thereof |
| 09/08/2006 | WO2006092326A2 Mimetic peptides and the use thereof in the form of 20s, 26s and immunoproteasome inhibitors |
| 09/08/2006 | WO2005051980A8 Depeptidized inhibitors of hepatitis c virus ns3 protease |
| 09/08/2006 | WO2004029071A3 Mage-c2 antigenic peptides and uses thereof |
| 09/08/2006 | CA2599876A1 Peptidomimetic compounds and preparation of biologically active derivatives |
| 09/08/2006 | CA2599864A1 Peptide-mimetics and use thereof as inhibitors of the 20s proteasome, 26s proteasome and the immunoproteasome |
| 09/07/2006 | WO2005074641B1 Variant neuronal nicotinic alpha-7 receptor and methods of use |
| 09/07/2006 | US20060199787 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
| 09/07/2006 | US20060199773 Crystalline forms of (1R,2S)-N-[(1,1-dimethylethoxy)carbonyl]-3-methyl-L-valyl-(4R)-4-[(6-methoxy-1-isoquinolinyl)oxy]-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenyl-cyclopropanecarboxamide, monopotassium salt |
| 09/06/2006 | EP1698629A2 Polyamines and their use in therapy |
| 09/06/2006 | EP1697411A1 Process for purifying interferon beta |
| 09/06/2006 | EP1697401A1 Tetrapeptide regulating blood glucose level in diabetes mellitus |
| 09/06/2006 | EP1697400A1 Biphenyl-substituted antibacterial macrocycles |
| 09/06/2006 | EP1696944A2 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 09/06/2006 | EP1514112B1 Method for identifying an allosteric effector of a receptor |
| 09/06/2006 | EP1497317B1 Dipeptidic growth hormone secretagogues |
| 09/06/2006 | EP1451208B1 Concentrating aqueous fractions of lisinopril by reverse osmosis |
| 09/06/2006 | CN1273444C Dipeptide nitriles |
| 09/05/2006 | US7101871 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/05/2006 | US7101864 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
| 09/05/2006 | US7101855 For therapy of inflammatory condition is selected from asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, tissue transplantation, tumor metastasis |
| 09/05/2006 | US7101854 Tetrapeptide stimulating the functional activity of hepatocytes, pharmacological substance on its basis and the method of its application |
| 09/05/2006 | US7101664 Using short chained amino acid sequences to increase yield of preferential cell products in animal or plant cultures; bioreactors |
| 08/31/2006 | WO2006090555A1 Akt ACTIVATING AGENT |
| 08/31/2006 | WO2006090289A2 Compounds for reducing aggregation of amyloid beta-peptide |
| 08/31/2006 | WO2006045066A3 Labeled compounds for proteasome inhibition |
| 08/31/2006 | WO2006038206A3 Compounds that modulate trh actions and inhibit the trh-degrading enzyme |
| 08/31/2006 | WO2005018554A3 Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy |
| 08/31/2006 | US20060194947 Peptide gap junction modulators |
| 08/31/2006 | US20060194742 Pyrane derivatives as both ACE- and NEP-inhibitors |
| 08/31/2006 | US20060194741 Dimeric IAP inhibitors |
| 08/31/2006 | US20060194281 decrease inhibit or prevent viral propagation or screening of compounds impaction on the expression of shorter form core+1 protein; antiviral agents |
| 08/31/2006 | US20060194259 Method for isolating an allosteric effector of a receptor |
| 08/31/2006 | US20060193773 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma |
| 08/31/2006 | CA2599291A1 Compounds for reducing aggregation of amyloid beta-peptide |
| 08/30/2006 | EP1695978A1 Nucleic acid ligands |
| 08/30/2006 | EP1695970A1 Peptides useful for competitive modulation of dipeptidyl peptidase IV catalysis |
| 08/30/2006 | EP1695712A2 Oral formulations for the selective inhibition of thrombin comprising boronic acid species |
| 08/30/2006 | EP1695711A2 Parenteral formulations comprising boronic acid species for selective thrombin inhibition |
| 08/30/2006 | EP1695703A2 Anticonvulsant amino acids for the treatment of pain |
| 08/30/2006 | EP1695702A2 Treatment of metastatic disease |
| 08/30/2006 | EP1445262B1 Peptide derivative, pharmaceutically acceptable salt thereof, process for producing the same, and use thereof |
| 08/30/2006 | CN1826352A Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 08/30/2006 | CN1826351A Novel method for the synthesis of perinidopril and the pharmaceutically acceptable salts thereof |
| 08/30/2006 | CN1826333A Diamine derivatives |
| 08/30/2006 | CN1826098A Production of small particles |
| 08/29/2006 | US7099534 Optical transmission device with optical waveguide coupled to optical device |
| 08/29/2006 | US7098308 Pentapeptide compounds and uses related thereto |
| 08/29/2006 | US7098305 Sustained release of microcrystalline peptide suspensions |
| 08/29/2006 | US7098304 Peptides that bind antibodies that are found in elevated levels in body fluids of schizophrenic patients and are found at a lower level or not found at all in body fluids of non-schizophrenic individuals |
| 08/29/2006 | US7098235 Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds |
| 08/29/2006 | US7098202 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/29/2006 | US7098186 Depsipeptide compound |
| 08/29/2006 | US7098024 Depsipeptide compound |
| 08/29/2006 | US7097824 Diagnosis images |
| 08/24/2006 | WO2006088248A1 Polyoxyalkylene derivative |
| 08/24/2006 | WO2006088245A1 Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative |
| 08/24/2006 | WO2006087550A2 Amyloid-binding peptides, analogues and uses thereof |
| 08/24/2006 | WO2006061714A3 Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis |
| 08/24/2006 | US20060189813 Amidating a 2,3,4,5,6,7-hexahydro-1H-indole-2-carboxylic acid or ester with a 2-substituted propionyl chloride in the presence of a base; amination with ethyl 2-aminovaleraate, and hydrogenation; uses readily obtainable starting materials; 1-(2-substituted propionyl)hexahydroindole-2-carboxylates |
| 08/24/2006 | US20060189810 Novel sulfonamide inhibitors of aspartyl protease |
| 08/24/2006 | US20060189657 Difluoroalkyl-subsituted amides such as morpholine-4-carboxylic acid {(S)-1-[(S)-1-(3-cyclopropyl-1,2,4-oxadiazole-5-carbonyl)-propylcarbamoyl]-3,3-difluoro-butyl}-amide; diseases associated wtih cathepsin S, K, and B such as neurodegenerative diseases, osteoporosis, emphysema, viral infection, cancer |
| 08/24/2006 | US20060189611 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/24/2006 | US20060189544 Integrin-Mediated drug targeting |